No Data
No Data
No Data
Why Are Xeris Biopharma Shares Moving Monday?
Xeris Biopharma Holdings, Inc (NASDAQ:XERS) shares are up Monday after the company announced an exclusive worldwide collaboration and license agreement with Beta Bionics.What Happened: In a new press
BenzingaMay 6 11:37 ET
Craig-Hallum Sticks to Their Buy Rating for Xeris Pharmaceuticals (XERS)
TipRanksMay 6 09:07 ET
Xeris Biopharma Collaborating With Beta Bionics for Development, Commercialization of Glucagon Product
Xeris Biopharma Holdings (XERS) said Monday it has entered into an exclusive worldwide collaboration and license agreement with Beta Bionics for the development and commercialization of a glucagon pro
MT NewswiresMay 6 07:42 ET
Express News | Xeris Shares Are Trading Higher After the Company Announced an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics
BenzingaMay 6 07:07 ET
Express News | Xeris Biopharma: Potential to Get Development Payments, Plus Low Double-Digit Royalties Based on Future Sales of Xeris Glucagon for Pumps, Pump Systems
ReutersMay 6 07:01 ET
Express News | Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics
ReutersMay 6 07:00 ET